NPR’s Scott Simon speaks with Dr. Monica Verduzco-Gutierrez about how sufferers with lengthy COVID are doing two years into the pandemic.
SCOTT SIMON, HOST:
President Biden declared the pandemic over on “60 Minutes” final Sunday. And whereas many Individuals are going round of their on a regular basis lives with out masks or assessments, many nonetheless deal with what’s grow to be often called lengthy COVID. Dr. Monica Verduzco-Gutierrez is professor and chair of the Division of Rehabilitation Drugs at College of Texas Well being San Antonio. And she or he treats folks with lengthy COVID. Physician, thanks a lot for being with us.
MONICA VERDUZCO-GUTIERREZ: Thanks for having me.
SIMON: You have been very blunt on Twitter. You referred to President Biden’s feedback as, quote, “a slap within the face” to thousands and thousands coping with lengthy COVID. Why did you see it that approach?
VERDUZCO-GUTIERREZ: As a result of these folks nonetheless are struggling. There’s not been the guarantees of help, of continued analysis, of any therapies. A variety of the therapies are only for people who find themselves acutely in poor health. And that is great, however now we want for the – therapies and help for the people who find themselves nonetheless struggling considerably.
SIMON: Properly, assist us perceive what some sufferers you’ve got seen are battling and the place they want help.
VERDUZCO-GUTIERREZ: So some sufferers are having vital, debilitating fatigue past what you and I might think about or, you already know, beforehand reside with. And a few of them are unable to get out of the house. There’s undoubtedly the chief dysfunction – you already know, what’s properly referred to as mind fog, however actually is points with processing, concentrating, arising with phrases, having the ability to do work. There’s sufferers which have points with their coronary heart price and their blood pressures once they rise up, and plus, improvement of latest power ailments that’s popping out of getting COVID-19 and lengthy COVID.
SIMON: What sort of therapies exist now?
VERDUZCO-GUTIERREZ: Properly, our therapy proper now’s symptom administration. We simply attempt to determine what we will diagnose. Have they got lung illness? We attempt to, you already know, deal with them with drugs we’ve got for that. Have they got dysautonomia or POTS? Then, you already know, there’s each conservative and medical administration for that. The fatigue, we simply give folks proper now, you already know, pacing and having them relaxation and sort of monitor and preserve their power.
SIMON: Melancholy turns into a difficulty, too?
VERDUZCO-GUTIERREZ: So despair turns into a secondary difficulty. You realize, you’ll – should you’re confronted with a brand new sickness that you simply weren’t coping with earlier than, should you’re realizing you are not getting help, if some folks could not imagine you, if even generally the medical institution is not supporting you, then folks can grow to be depressed. It additionally goes with a few of the irritation that is taking place within the mind after COVID. One examine had lately got here out and mentioned, you already know, there could also be early on temper issues, despair, anxiousness, however over two years that bought higher. However the neurologic, the cognitive stuff didn’t.
SIMON: Two years?
VERDUZCO-GUTIERREZ: Two years. Persons are nonetheless affected by the start, from March 2020.
SIMON: The place, in your judgment, can the federal government and well being care authorities be most supportive proper now?
VERDUZCO-GUTIERREZ: I believe, you already know, we actually want to begin trials for therapies for these sufferers. I believe additionally there are a number of payments which can be, you already know, each within the Home and the Senate that could be on the market, however they are not being pushed via, that provide each help for sufferers and help for clinics and for analysis. And people are simply sort of stalled there.
SIMON: I imply, recognizing that we’ve got clearly discovered over centuries that you simply simply cannot snap your fingers and provide you with a completely efficient therapy, a lot much less something that is like a remedy, might we, as a society, make investments extra to find some sort of therapies that might work in the way in which that vaccines have been so rapidly developed?
VERDUZCO-GUTIERREZ: There’s been post-infectious ailments for a very long time, and we have sort of ignored them, however now we can not ‘trigger the quantity is so enormous. And I believe that that is the chance to say, let’s deliver consideration to, you already know, the individuals who’ve been struggling even earlier than the pandemic, who even have related forms of photos as lengthy COVID. And, you already know, there are some issues which can be already accessible. We’ve got Paxlovid. We’ve got remdesivir. We’ve got these antivirals. Why aren’t we doing antiviral trials, particularly once they already know there’s generally persistence of the viral antigens in folks’s our bodies with lengthy COVID? We all know there’s an autoimmune phenomenon. Why aren’t we making an attempt autoimmune drugs for the immune system that we already know exist?
SIMON: Physician, how did you end up working with lengthy COVID sufferers, a specialty that didn’t exist two years in the past?
VERDUZCO-GUTIERREZ: Proper. So we noticed that there was a giant want, that there was – you already know, folks have been being massively impacted by COVID-19. And I mentioned as a rehabilitation specialist, that is our time to come back in and shine and have the ability to handle folks with these, you already know, horrible impacts. And I am additionally – concentrate on mind harm drugs, and it occurs to be a variety of the signs are very related – fatigue, mind fog, focus points, dizziness, complications, incapability to return to work. So it is sort of what I had accomplished earlier than, however now in a brand new inhabitants of sufferers. After which the opposite factor is I felt like – I am in San Antonio, we’ve got a big majority minority metropolis, a variety of Latinos right here, and it is a inhabitants that I knew was going to be impacted extra. We have seen that in COVID-19, so I mentioned we have to begin rehabilitating them and addressing the wants after COVID-19.
SIMON: Dr. Monica Verduzco-Gutierrez is a professor and chair on the Division of Rehabilitation Drugs at UT Well being in San Antonio. Thanks a lot for being with us, and good luck to you and your sufferers.
(SOUNDBITE OF ROB BURGER’S “DIMINISHED CAPACITY”)
NPR transcripts are created on a rush deadline by an NPR contractor. This textual content is probably not in its last type and could also be up to date or revised sooner or later. Accuracy and availability could fluctuate. The authoritative document of NPR’s programming is the audio document.